诱导多能干细胞
良好制造规范
再生医学
人诱导多能干细胞
干细胞
医学
生物技术
风险分析（工程）
生物
胚胎干细胞
细胞生物学
生物化学
基因
监管事务
作者
Adeleh Taei,Fatemehsadat Sajadi,Sarvenaz Salahi,Zahra Enteshari,Nasrin Falah,Zahra Shiri,Saeed Abasalizadeh,Ensiyeh Hajizadeh‐Saffar,Seyedeh‐Nafiseh Hassani,Hossein Baharvand
标识
DOI：10.1080/14712598.2024.2443079
摘要
hPSC-based products continue to show promise for the treatment of a variety of diseases. While clinical trials support the relative safety and efficacy of hPSC-based products, further investigation is required to explore the clinical challenges and achieve exclusive regulations for hPSC-based cell therapies.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
null
Criminology34
ceeray23
MchemG
yyds
andrele
辉辉
叶上
殷勤的紫槐
无极微光
YifanWang
叽了咕噜
笔记本
tuanheqi
荼黎
mmyhn
皮皮
精明浩然
Tourist
Hayat
子车茗
什么时候能毕业
Zhusfeng
Alex
皖公网安备34019202002308
